Schrewe H et al., found that a CEA gene promoter construct demonstrated anticancer activity that was nine times greater against the CEA-producing adenocarcinoma cell line SW403 than the non-CEA-producing HeLa cell line [20]. Here, CEACAM5 is linked to adenocarcinoma.